A method of prognosing and stratifying treatment of glioma based on transcriptional activation of immunomodulating endogenous retroviruses (ERVs) in tumor microenvironment (TME)
Patent inventors: Dąbrowski Michał, Kamińska-Kaczmarek Bożena, Maleszewska-Bobińska Marta, Mondal Shamba, Wojtas Bartosz

A description of the invention will be available after the patent application is published.

Nencki Institute is the sole applicant.

For more information contact Technology Transfer Office.

Application number:
EP22198465.1 (28.09.2022)
Patent status: